Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma

Background Carcinomas of the small bowel are rare tumors usually with dismal prognosis. Most recently, some potentially treatable molecular alterations were described. We emphasize the growing evidence of individualized treatment options in small bowel carcinoma.